CAR T-Cell Therapy Achieves Lasting Remission in Child’s Liver Cancer
Pharmacies must balance trust with digital convenience
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
Adjuvant Osimertinib Shows 8-Year Survival Benefit in Lung Cancer
Ivonescimab improves survival over pembrolizumab in advanced lung cancer
Canada Overhauls Medical Education With New Schools Programs

Experts Offer Mentorship Advice for New Neurologists

Pharmacists fill vaccination gap as measles cases surge

Clinics recruit future medical administrators

Air crews face higher cancer death risk
FDA approves first treatments for rare ataxia disorders
Monocytes predict vaccine side effects
Monocytes may predict vaccine side effects in individuals after receiving an mRNA vaccine.
Dapagliflozin Reduces Heart Failure Risks, Regardless of Congestion
Dapagliflozin reduces heart failure risks regardless of congestion, according to the DAPA ACT HF-TIMI 68 trial.
Sotatercept Added to PAH Treatment Guidelines
Sotatercept is added to PAH treatment guidelines as an additional therapy for patients.
New lung cancer drug dosing shows promise for patient convenience
New lung cancer drug dosing (Tarlatamab) offers pharmacists flexibility with every 3-4 week schedules, maintaining efficacy per DeLLphi-309 study results.
Cancer rates rise among 9/11 survivors
9/11 survivors see cancer cases surge, with a new study reporting a 2.5‑fold rise in diagnoses since 2019 among those…
MedTech Devices Evolve, Pushing Materiovigilance Ahead
Materiovigilance helps monitor safety issues with medical devices as medtech evolves, ensuring patient safety through continuous evaluation of malfunctions and
Second CaRMS round offers 181 spots 139 family
Dolly Parton Stays in Line Refuses Shortcuts
Ottawa Med School Focuses on Seven Interview Competencies

AI tools improve medical device safety checks

MedTech firms advance lean manufacturing techniques

Pharmacist Publishes Guide to Pass PEBC Exam
U of A offers AI, health, population certificates
U of A launches an AI health certificate and population health credential for health professionals, tackling workforce shortages and fast…
Research Reveals Trends in Male Female Hair Loss
Hair loss trends show androgenetic alopecia impacts men and women, and early dermatologist care can slow progression and boost quality…
Four Myths About Regenerative Medicine Therapy
Regenerative medicine therapy, such as stem cell or platelet-rich plasma injections, is one of the fastest-growing practices in the medical…
Latest News
FDA approves first treatments for rare ataxia disorders
The FDA has approved the first treatments for rare ataxia disorders, including Omaveloxolone for Friedreich ataxia and levacetylleucine…
Experts Offer Mentorship Advice for New Neurologists
Experts Blake Buletko and Galina Gheihman discuss neurologist mentorship advice for new doctors transitioning to practice. Explore essential…
FDA Grants Fast Track Status to Apitegromab
FDA grants fast track status to apitegromab for muscular dystrophy treatment, showing urgency in advancing new treatments.
CAR T-Cell Therapy Achieves Lasting Remission in Child’s Liver Cancer
CAR T-cell therapy achieves lasting remission in a child's liver cancer, offering hope for chemotherapy-resistant cases.
Pharmacies must balance trust with digital convenience
Pharmacies must balance trust with digital convenience to meet patient expectations and satisfaction.
Monocytes predict vaccine side effects
Monocytes may predict vaccine side effects in individuals after receiving an mRNA vaccine.
Dapagliflozin Reduces Heart Failure Risks, Regardless of Congestion
Dapagliflozin reduces heart failure risks regardless of congestion, according to the DAPA ACT HF-TIMI 68 trial.
FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A
The FDA approves first gene therapy, Fayuvi, for Sanfilippo syndrome type A, offering a disease-modifying treatment for MPS…
Sotatercept Added to PAH Treatment Guidelines
Sotatercept is added to PAH treatment guidelines as an additional therapy for patients.
Adjuvant Osimertinib Shows 8-Year Survival Benefit in Lung Cancer
Adjuvant osimertinib offers an 8-year survival benefit for resected EGFR-mutated NSCLC patients, per the ADAURA trial at the…